- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1,655)
7 result(s) found for: Erm.
Displaying page 1 of 1.
EudraCT Number: 2007-003097-26 | Sponsor Protocol Number: GELLC-2 | Start Date*: 2007-12-22 |
Sponsor Name:Francesc Bosch Albareda | ||
Full Title: Tratamiento de rescate con Rituximab-CHOP seguido de Alemtuzumab (R-CHOP-A) en pacientes con leucemia linfática crónica refractarios o racaidos tras tratamiento con análogos de las purinas. | ||
Medical condition: Tretamiento de rescate con Rituximab-CHOP seguido de Alemtuzumab en pacientes con elucemia linfática crónica refactarios o recaidos tras tratamiento con análogos de las purinas. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000741-39 | Sponsor Protocol Number: 6996 | Start Date*: 2019-11-07 |
Sponsor Name:Hôpitaux Universitaires de Strasbourg | ||
Full Title: EFFECT OF AZITHROMYCIN ON THE PROPORTION OF FAILURES OF SEVERE PERIODONTITIS NON-SURGICAL TREATMENTS : A RANDOMIZED, DOUBLE-BLIND VERSUS PLACEBO STUDY | ||
Medical condition: Periodontology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-006023-33 | Sponsor Protocol Number: SIMFIB | Start Date*: 2021-10-26 | ||||||||||||||||
Sponsor Name:Institut d’Investigacions Biomèdiques August Pi i Sunyer | ||||||||||||||||||
Full Title: Efficacy of simvastatin reducing liver fibrosis in patients with advanced fibrosis due to alcohol: a randomized, double-blind, placebo-controlled clinical trial. | ||||||||||||||||||
Medical condition: reduction of liver fibrosis in patients with advanced fibrosis due to alcohol | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012083-14 | Sponsor Protocol Number: EPC2008-02 | Start Date*: 2009-06-17 | |||||||||||
Sponsor Name:MEDA Pharma GmbH & Co. KG | |||||||||||||
Full Title: An Open-Label, Multicenter Study of the Effects of Remission Maintenance Therapy with Ceplene® (Histamine Dihydrochloride), Given in Conjunction with Low-Dose Interleukin-2 (IL-2, Proleukin®), on I... | |||||||||||||
Medical condition: Acute Myeloid Leukemia in First Complete Remission (CR1) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) BE (Prematurely Ended) GB (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000839-10 | Sponsor Protocol Number: PKU-008 | Start Date*: 2006-08-09 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Phase 3b, Multicenter, Open-Label Extension Study of Phenoptin in Subjects with Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006 | |||||||||||||
Medical condition: Phenylketonuria (PKU) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IE (Completed) ES (Ongoing) GB (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017454-12 | Sponsor Protocol Number: U01–NS052220 | Start Date*: 2011-02-04 | ||||||||||||||||
Sponsor Name:University of Cincinnati - Academic Medical Center -Department of Neurology | ||||||||||||||||||
Full Title: INTERVENTIONAL MANAGEMENT OF STROKE TRIAL CLINICAL PROTOCOL A phase III, randomized, multi-center, open label, 900 subject clinical trial that will examine whether a combined intravenous (IV) and i... | ||||||||||||||||||
Medical condition: Ischemic Stroke | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) ES (Temporarily Halted) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001626-27 | Sponsor Protocol Number: CC-5013-CLL-002 | Start Date*: 2009-04-14 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF LENALIDOMIDE (REVLIMID®) AS MAINTENANCE THERAPY FOR PATIENTS WITH B-CELL CHR... | |||||||||||||
Medical condition: Relapsed or refractory B-cell chronic lymphocytic leukemia (CLL) who have achieved at least partial response (PR) to second-line therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) BE (Completed) ES (Completed) HU (Completed) CZ (Completed) PT (Completed) AT (Completed) IT (Completed) DK (Completed) FR (Completed) SE (Completed) NL (Completed) IE (Completed) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.